Breast Cancer Clinical Trial
Official title:
The Effect on Clip Markers Migration After Vacuum-Assisted Biopsy by Postprocedure Mammogram
Primary Objective:
- To perform a prospective study to determine if there is a different in the marker clip
migration if the first post-biopsy mammogram was performed in the same projection as the
core biopsy versus in the orthogonal projection.
You are scheduled to have a biopsy because a lesion was seen on your mammogram. Sometimes,
the lesion is completely removed during the biopsy. Therefore, a clip is usually placed to
mark the biopsy site. If some of the tissue in this area needs to be removed by a surgeon at
a later date, the clip will mark the area for your surgeon to remove.
All participants in this study will already be scheduled for a stereotactic biopsy with clip
placement followed by a mammogram, as a part of the standard of care. You will need to sign
a separate consent document for these procedures.
Before you can start treatment on this study, you will have "screening tests." These tests
will help the doctor decide if you are eligible to take part in this study. Blood (about 1
teaspoon) will be drawn for routine tests. Women who are able to have children must have a
negative blood (about 1 teaspoon) pregnancy test before they can take part in this study.
If you are eligible and you choose to take part in this study, you will be randomly assigned
(as in the toss of a coin) to one of two study groups. There will be an equal chance of
being assigned to either group.
If you are assigned to Group 1, your breast will be compressed the same way as the breast
was compressed during the biopsy in the first mammogram picture. In the second picture, your
breast will be compressed the opposite way (a 90-degree rotation) from the way the first
picture was done.
If you are assigned to Group 2, your breast will be compressed in a 90-degree rotation from
the way the breast was compressed during your biopsy in the first mammogram picture. In the
second picture, your breast will be compressed the same way as during the biopsy.
A researcher will review the mammogram to measure and record the distance of the biopsy clip
from the biopsied lesion.
If your biopsy is benign (non-cancerous), you will return to the clinic for a mammogram once
a year, as is standard of care. Researchers would like to review the mammogram that is taken
1 year after the biopsy in order to check to see if the clip has moved or stayed in the same
place.
This is an investigational study. The clip used in this study is FDA approved. Up to 60
patients will take part in the study. All will be enrolled at M.D. Anderson Cancer Center.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |